Table 3.
Potential electronic-nose applications for human and animal disease diagnoses via detection of volatile biomarker indicator compounds.
| Disease/Disorder/Infection | Aroma sample source | Associated volatile biomarkers† | References |
|---|---|---|---|
| Aerobic gram negative bacteria | Intraperitoneal fluid | Terpenes, ketones | [10] |
| Alcoholic fatty liver disease (AFDL) | Human breath | Acetaldehyde, isoprene, 3 other unidentified VOCs | [240] |
| Alcohol-induced hepatic injury | Human breath | Ethane, pentane (volatile alkanes) | [241] |
| Allograft rejection | Human breath | Carbonyl sulfide | [242] |
| Anaerobic bacterial infections | Intraperitoneal fluid | Acetic acid, butyric acid | [243] |
| Urine | Isobutylamine, acetic acid, butyric acid | [106,244,245] | |
| Asthma | Human breath | Pentane, ethane, 8-isoprostane, nitric oxide, leukotriene B4, prostaglandin E2 | [246–253] |
| Bacteremia | Blood cultures | Specific complex mixture of VOCs | [254] |
| White blood cell cultures | Acetaldehyde, hexanaldehyde | [255] | |
| Bacterial infections (local) | Human pus | Isobutyric, isovaleric, & isocaproic acids | [256] |
| Bacterial vaginosis | Vaginal swabs | Specific complex mixture of VOCs | [257] |
| Bacteriuria | Urine | Specific complex mixture of VOCs | [258] |
| Breast cancer | Human breath | C4-C20 alkanes, monomethylated alkanes | [67] |
| Cardiopulmonary disease | Alveolar air | Ethanol, acetone | [259] |
| Cholera | Feces | p-menth-1-en-8-ol, dimethyl disulphide | [260] |
| Chronic hepatitis | Alveolar air | Methyl-mercaptan, dimethyl sulfide | [261] |
| Chronic obstructive pulmonary disease (COPD) | Human breath | NO, H2O2, aldehydes, 8-isoprostane, nitrotyrosine, Leukotriene B4, cytokines | [99,100,262–265] |
| Cystic fibrosis | Human breath | Leukotriene B4, interleukin-6, carbonyl sulfide, alkanes | [192,266] |
| Cystinuria | Human breath | Cadaverine, piperidine, putrescine, pyrrolidine | [42,267] |
| Diabetes mellitus | Human breath | Acetone, ethanol, methyl nitrate, complex VOCs | [226,268] |
| Eye infections | Cultures of ocular fluids | Specific complex mixture of VOCs | [176] |
| Foetor hepaticus | Human breath | Specific complex mixture of VOCs | [269] |
| Haematuria | Urine | Specific complex mixture of VOCs | [270] |
| Halitosis | Human breath | Hydrogen sulfide, methyl mercaptan, dimethyl sulfide | [271] |
| Hepatic cirrhosis | Alveolar breath | Dimethyl sulfide, hydrogen sulfide, mercaptans, volatile fatty acids | [272] |
| Alveolar air | Dimethyl sulfide, acetone, 2-pentanone and 2-butanone | [273] | |
| chronic hepatitis | Methyl-mercaptan, dimethyl sulfide | [261,239] | |
| Hepatic coma | Alveolar air | Methyl-mercaptan, dimethyl sulfide | [261,239,274] |
| Hepatic encephalopathy | Blood plasma, spinal fluid | 3-methylbutanal | [72] |
| Histidinemia | Human breath | 2-imidazolepyruvic acid, 2-imidazolelactic acid, 2-imidazoleacetic acid | [42] |
| Hyperglycemia | Human breath | Methyl nitrate, xylene, ethylbenzene | [183,268] |
| Inflammatory bowel disease (IBD) | Human breath | Pentane, ethane, propane | [73,275–277] |
| Isochemic heart disease, angina | Human breath | Alkanes, methylated alkanes | [278,279] |
| Ketosis | Alveolar air | Acetone | [76] |
| Leg ulcers & wound healing | Contact dressings | Specific complex mixture of VOCs | [280,281] |
| Liver cancer | Blood | Hexanal, 1-octen-3-ol, octane | [282] |
| Lung cancer | Human breath | Alkanes, monomethylated alkanes | [64,278] |
| Human breath | Alkanes, aromatic compounds | [283] | |
| Human breath | Specific complex mixture of VOCs | [234,284–286] | |
| Maple syrup urine disease | Human breath | 2-oxoisocaproic acid | [42] |
| Metabolic disorders | Urine | Isovaleric acid | [287] |
| Necrotizing enterocolitis (NEC) | Feces | 2-Ethyl-1-hexanol, fewer esters present in VOCs | [288] |
| Oxidative stress | Human breath | 8-isoprostane | [247] |
| Phenylketonuria | Human breath | Phenylpyruvic acid, phenyllactic acid, phenylacetic acid | [42] |
| Renal dysfunction and failure | Urine | Specific complex mixture of VOCs | [270] |
| Respiratory infections | Human breath | Specific complex mixture of VOCs | [289] |
| Rheumatoid arthritis | Alveolar air | Pentane | [290] |
| Tyrosinemia | Human breath | p-hydroxyphenylpyruvic acid | [42] |
| Schizophrenia | Alveolar air | Pentane, carbon disulfide, ethane | [34,35,291] |
| Sweaty feet syndrome | Urine, sweat, human breath | Butyric acid, hexanoic acid; trans-3-methyl-2 hexenoic acid | [37] |
| Urinary tract infection | Urine | Isovaleric acid, alkanes | [245] |
| Urine | Specific complex mixture of VOCs | [245,292] |
Bio-indicator compounds are volatile organic compounds (VOCs) that usually were initially identified and confirmed using gas chromatography-mass spectroscopy (GC-MS) or similar analytical equipment prior to development of corresponding e-nose reference libraries for detection.